Affiliation:
1. The University of Texas Health Science Center at Houston
Abstract
Abstract
Tumorigenic functions due to the formation of fusion genes were targeted for cancer therapeutics (i.e., kinase inhibitors). However, many fusion proteins are still awaiting being targeted for therapeutics in diverse cellular working mechanisms. Due to the lack of whole fusion protein sequences and whole 3D structures of the fusion proteins, it was hard to develop novel therapeutic approaches. To fill these critical gaps, we developed a new computational pipeline and a resource of human fusion proteins named FusionPDB, available at https://compbio.uth.edu/FusionPDB. FusionPDB provides ~ 43K fusion protein sequences (of 14.7K in-frame fusion genes, Level 1), 2300 + 1267 fusion protein 3D structures (of 2300 recurrent + 266 manually curated in-frame fusion genes, Level 2), and virtual screening results of 1267 fusion proteins (of 266 manually curated in-frame fusion genes, Level 3). FusionPDB is the only resource providing whole 3D structures of fusion proteins and comprehensive knowledge of human fusion proteins. It will be regularly updated until covering all human fusion proteins in the future.
Funder
National Institute of General Medical Sciences
Publisher
Research Square Platform LLC
Reference28 articles.
1. Kinase-targeted cancer therapies: progress, challenges and future directions;Bhullar KS;Mol Cancer,2018
2. A recent update on small-molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry-based proteomic analysis;Lee PY;FEBS J,2022
3. FGviewer: an online visualization tool for functional features of human fusion genes;Kim P;Nucleic Acids Res,2020
4. STRING: a database of predicted functional associations between proteins;Mering Cv;Nucleic acids research,2003
5. Highly accurate protein structure prediction with AlphaFold;Jumper J;Nature,2021